Influenza Virus-Like Particles Produced in Nicotiana benthamiana Protect Against a Lethal Viral Challenge in Mice

[1]  Brian J. Ward,et al.  Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza , 2010, PloS one.

[2]  L. Vézina,et al.  The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. , 2010, Plant biotechnology journal.

[3]  Brian J Ward,et al.  Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. , 2008, Plant biotechnology journal.

[4]  K. Musiychuk,et al.  A launch vector for the production of vaccine antigens in plants , 2007, Influenza and other respiratory viruses.

[5]  F. Altmann.  The Role of Protein Glycosylation in Allergy , 2006, International Archives of Allergy and Immunology.

[6]  D. Ebo,et al.  Sensitization to cross‐reactive carbohydrate determinants and the ubiquitous protein profilin: mimickers of allergy , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  S. Scheurer,et al.  Biological activity of IgE specific for cross-reactive carbohydrate determinants. , 2003, The Journal of allergy and clinical immunology.

[8]  P. Gómez-Puertas,et al.  Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding , 2000, Journal of Virology.

[9]  R. Van Ree,et al.  β(1,2)-Xylose and α(1,3)-Fucose Residues Have a Strong Contribution in IgE Binding to Plant Glycoallergens* , 2000, The Journal of Biological Chemistry.

[10]  P. Rellos,et al.  Expression, Purification, and Characterization of Natural Mutants of Human Aldolase B , 2000, Journal of Biological Chemistry.

[11]  R. Van Ree,et al.  Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins. , 1997, The Journal of allergy and clinical immunology.

[12]  D. M. Lam,et al.  Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Tacket.  Plant-Based Oral Vaccines: Results of Human Trials , 2009, Current topics in microbiology and immunology.